Association of secondary somatic mutations in BRCA1/2 with clinical resistance to PARP inhibitors and chemotherapy.
暂无分享,去创建一个
X. Yi | Y. Guan | Ling Yang | X. Xia | Lingjun Zhu | Chi-zhi Zhang | P. Dai | Yan Zhang | Hui Li | P. Zhou | Chun‐wei Xu | W. Wang